NEW YORK--(

纽约--(

BUSINESS WIRE

商业热线

)--

)--

Synchron

Synchron公司

, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of neurotechnology. Synchron’s BCI technology, in combination with the

一家定义类别的脑机接口（BCI）公司今天宣布，植入式脑机接口技术向前迈出了一步，以推动神经技术的未来。Synchron的BCI技术与

NVIDIA Holoscan platform

NVIDIA全息扫描平台

, is poised to redefine the possibilities of real-time neural interaction and intelligent edge processing.

，有望重新定义实时神经交互和智能边缘处理的可能性。

Synchron will leverage NVIDIA Holoscan to advance a next-generation implantable BCI in two key domains. First, Synchron will enhance real-time edge AI capabilities for on-device neural processing, improving signal processing and multi-AI inference technology. This will reduce system latency, bolster privacy, and provide users with a more responsive and intuitive BCI experience.

Synchron将利用NVIDIA Holoscan在两个关键领域推进下一代植入式BCI。首先，Synchron将增强设备上神经处理的实时边缘AI能力，改进信号处理和多AI推理技术。这将减少系统延迟，增强隐私，并为用户提供更灵敏和直观的BCI体验。

NVIDIA Holoscan provides Synchron with: (i) a unified framework supporting diverse AI models and data modalities; (ii) an optimized application framework, from seamless sensor I/O integration, GPU-direct data ingestion, to accelerated computing and real-time AI..

NVIDIA Holoscan为Synchron提供：（i）支持多种AI模型和数据模式的统一框架；（ii）从无缝传感器输入/输出集成、GPU直接数据接收到加速计算和实时AI的优化应用框架。。

Second, Synchron will explore the development of a groundbreaking foundation model for brain inference. By processing Synchron’s neural data on an unprecedented scale, this initiative will create scalable, interpretable brain-language models with the potential to transform neuroprosthetics, cognitive expression, and seamless interaction with digital devices..

其次，Synchron将探索大脑推理的开创性基础模型的发展。通过以前所未有的规模处理Synchron的神经数据，这一举措将创建可扩展的，可解释的大脑语言模型，具有改变神经假体，认知表达以及与数字设备无缝交互的潜力。。

“Synchron’s vision is to scale neurotechnology to empower humans to connect to the world, and the NVIDIA Holoscan platform provides the ideal foundation,” said Tom Oxley, M.D., Ph.D., CEO & Founder, Synchron. “Through this work, we’re setting a new benchmark for what BCIs can achieve.”

Synchron首席执行官兼创始人、医学博士汤姆·奥克斯利（TomOxley）表示：“Synchron的愿景是扩展神经技术，使人类能够与世界联系，而NVIDIA Holoscan平台提供了理想的基础。”。“通过这项工作，我们正在为BCIs能够实现的目标设定一个新的基准。”

About Synchron

关于Synchron

Synchron is the leading implantable brain-computer interface company, pioneering neurotechnology designed to restore functionality for individuals with paralysis by expanding autonomy. Since 2019, Synchron has completed two human clinical trials and is now preparing for a larger-scale clinical study with a device optimized for scalable manufacturing.

Synchron是领先的植入式脑机接口公司，开创了神经技术的先河，旨在通过扩大自主性来恢复瘫痪患者的功能。自2019年以来，Synchron已经完成了两项人体临床试验，目前正在准备进行更大规模的临床研究，该研究采用了针对可扩展制造进行优化的设备。

The company has an exclusive partnership with flexible MEMs manufacturer Aquandas, ensuring access to cutting-edge technology for their innovative devices. The BCI market represents a $400 billion opportunity (Morgan Stanley report), and Synchron is at the forefront, defining the category and pushing the boundaries of what’s possible in neuroprosthetics and digital autonomy.

该公司与柔性MEMs制造商Aquandas建立了独家合作关系，确保其创新设备获得尖端技术。BCI市场代表着4000亿美元的机会（摩根士丹利报告），Synchron处于最前沿，定义了类别，并推动了神经假体和数字自主的可能性。

Headquartered in New York City, Synchron is shaping the future of neurotechnology. For more information, visit .

Synchron总部位于纽约市，正在塑造神经技术的未来。有关更多信息，请访问。

www.synchron.com

www.synchron.com

and follow us

跟着我们

@synchroninc

@同步

.

.